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The latex of Himatanthus sucuuba (Spruce) Woodson, used popularly in the Amazon for the treatment 
of tumors, gastritis, inflammations and infections, was evaluated for cytotoxicity and antibacterial 
activities. The iridoid lactones, plumericin and isoplumericin were isolated from latex by bioassay 
fractionation and were found to be associated with DNA damage. Gallic acid exhibited the highest 
antimicrobial activity among the phenolic compounds isolated from the aqueous fraction. The 
compounds associated to cytotoxicity and antimicrobial activities could be responsible to the effects of 
this species used in traditional medicine. 
 





In Brazil, there are about 90 genera and 850 species of 
the Apocynaceae family, divided into various formations 
(Souza and Lorenzi, 2005). Some species of this family 
such as Himatanthus sucuuba (Spruce) Woodson, are of 
therapeutic value and have a long history of use in folk 
medicine of Brazil. A recent review described the mor-
phology, chemistry, pharmacology and ethnopharma-
cology of this species which is popularly known as 
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Abbreviations: TLC, Thin layer chromatography; MIC, 
minimum inhibitory concentration; IC12, concentration (µg/ml) is 
required to produce a zone of inhibition of 12 mm; MeOH, 
methanol; EtOAc, ethyl ethanoate; n-BuOH, n-butanol; GC/MS, 
gas chromatography coupled with mass spectrophometer; 
NMR, nuclear magnetic resonance; MPLC, medium pressure 
liquid chromatography. 
names (Amaral et al., 2007).  
The latex and bark of this plant are mainly used in folk 
medicine for the treatment of ulcers, infections, inflame-
matory processes and tumors (Van Den Berg, 1982; 
Perdue and Blomster, 1978; Schultes, 1979; Bourdy et 
al., 2000; Villegas et al., 1997). Previous studies of H. 
sucuuba bark and latex have shown the antifungal and 
antiprotozoal activity of iridoid lactones (Silva et al., 1998; 
Castillo et al., 2007) and the anti-inflammatory activity of 
triterpenoids (Miranda et al., 2000). In this study, iridoids 
and phenolic compounds were isolated for the first time 
from the latex of this species. Bioassays-guided fractio-
nations were used to identify the compounds responsible 
for the antitumor and antibacterial activities of the latex 
from this plant.  
 
 






Plant samples were collected in Santarém  city,  Pará  State  and  a 




voucher specimen (number 5436) was deposited at the Herbarium 
of the Federal University of Amazonas, Manaus, AM, Brazil.  
 
 
Obtaining Latex  
 
The latex was removed from some cuts in the bark with the help of 
a damp sponge. The material was collected in a bottle and then 
stored at 4°C. 
 
 
Extraction of latex and isolation of the compounds 
 
Liquid-liquid extraction was performed on the latex of H. sucuuba 
as described previously (Barreto et al., 2007). The hexane fraction 
(12.0 g) was separated on a Sephadex LH-20 column, and eluted 
successively with hexane, dichloromethane (CH2Cl2) and methanol 
(MeOH). The hexane fraction was also subjected to preparative thin 
layer chromatography (TLC) (Hexane: EtOAc, 6:4) in order to 
isolate a mixture of plumericin and isoplumericin (8:2, 5.0 mg, 
0.04% of the extract). Plumericin and isoplumericin were identified 
by spectroscopic methods (NMR and GC/MS) and by comparison 
with literature data (Trost et al., 1986; Abdel-Kader et al., 1997). 
The aqueous fraction was successively partitioned with CHCl3 and 
after lyophilized. This powdered fraction (2.4 g) was submitted to 
reverse phase C-18 medium pressure liquid chromatography 
(MPLC) with water up to water/MeOH (1:1), flow 6 ml/min. 26 
fractions of 40 ml were obtained and combined in two principal 
fractions: A (0.63 g) and B (1.8 g). The fraction A was chroma-
tographed on Sephadex LH-20 column with water/MeOH (7:3) as 
eluent, for the isolation of catechol (39.5 mg). The fraction B was 
subjected to Sephadex LH-20 chromatography with MeOH as 
eluent and also on HPLC column (twice) RP-18 (Shimadzu, 45 x 
250 mm, 10 µm particle size) and water/MeOH (6:4) as eluent, for 
the isolation of three compounds: gallic acid (16.6 mg), myricetrin 
(3.9 mg) and quercitrin (4.7 mg). The compounds were identified by 
spectroscopic methods and by comparison with data in the 
literature (Chanwitheesuk et al., 2007; Mabry et al., 1970). The 
flavonoids were also identified by UV spectroscopy using shift 







The microorganisms used in this study were Staphylococcus 
aureus (MRSA), Staphylococcus epidermidis (ATCC 12228), 
Staphylococcus haemolyticus (ATCC 2737), Proteus mirabilis 
(MRSA), Shigella sonnei (ATCC 25931), Salmonella typhimurium 
(ATCC 13311) and Escherichia coli (ATCC 25922). All MRSA 
bacteria were identified by traditional biochemical tests and 
according to National Committee for Clinical Laboratory Standards 
(NCCLS) (Machado et al., 2003). 
 
 
Disc diffusion method  
 
The antibacterial activity of the samples was determined using the 
disc diffusion method (Machado et al., 2003). Varying amounts of 
sample (25, 50, 100, 250, 500 and 1000 µg) were applied to sterile 
filter paper discs (6 mm in diameter). Antibacterial activity was 
determined by measuring the diameter (d) of the inhibition zone 
formed around the disk (considered 10 - 18 mm). 
 
 
Minimum inhibitory concentration (MIC) 
 





concentration (MIC) assays were undertaken according to metho-
dology adopted from National Council for Clinical Laboratory 
Standards (1993). Concentrations ranging from 15.5 to 500 µg/ml 
were used for each sample. The MIC is defined as the lowest 
concentration of the sample at which visible growth of the micro-
organism is completely inhibited.  
 
 
Mechanism-based yeast bioassay for DNA damaging activity 
 
The assay was evaluated using genetically engineered mutants of 
yeast of Saccharomyces cerevisiae as described previously 
(Gunatilaka et al., 1992). The IC12 is defined as the concentration in 
µg/ml that is required to inhibit growth over a 12 mm diameter in a 
100 µl well after 48 h incubation at 37°C. Camptothecin (RS188N 




RESULTS AND DISCUSSION 
 
Bioassay fractionation of the latex extract was used to 
identify substances that could be related to the ethno-
pharmacological use of H. sucuuba. The fractionation 
was performed as follows: n-BuOH was added to the 
crude latex of this species to promote polyisoprene 
precipitation. The organic (n-BuOH) and aqueous frac-
tions were separated, evaporated and assayed against 
mutant strains of S. cerevisae. This assay utilizes DNA 
repair or recombination deficient mutants of the yeast S. 
cerevisiae for the screening of compounds, which induce 
DNA damage. This mechanism-based yeast assay de-
pends on the different responses of DNA repair-deficient 
and repair proficient yeast (S. cerevisiae) strains to the 
sample. The major DNA repair pathway is RAD52 
pathway associated with the repair of double strand 
break and meiotic recombination (Gunatilaka et al., 
1994). A mutant rad52 repair-deficient strain, rad52.top1, 
with the additional deletion of the DNA topoisomerase I 
gene is also available and can detect agents that produce 
DNA damage specifically by interacting with DNA 
topoisomerase (Gunatilaka et al., 1994). An extract is 
considered active if it shows selective activity against one 
or more repair-deficient yeasts and has an IC12 less than 
2000 µg/ml (Gunatilaka et al., 1994). The results are 
shown in Table 1. Only the n-BuOH fraction exhibited 
activity with an IC12 = 1641 µg/ml (rad52.top1). The n-
BuOH fraction was then partitioned with a solution of 
MeOH (80%) and hexane. Enhanced activity was exhi-
bited by the hexane fraction, with an IC12 = 542 µg/ml 
(rad52.top1). Column and preparative TLC were perfor-
med on the hexane fraction and the activity of isolated 
compounds was determined. The iridoid lactones 
(plumericin (1) and isoplumericin (2) showed relevant 
activity against rad52.top1 (IC12 = 32.8 µg/ml). The act-
ivity of the iridoids against rad52 yeast strains was 
approximately four times lower (IC12 = 112.3 µg/ml) and 
nine times less effective against repair-proficient strains 
(RS188N, IC12 = 289.0 µg/ml) than against rad52.top1. 
These results indicated, for the first time, that this mixture  




Table 1. Activity of the fractions and iridoids from H. sucuuba against mutant strains of S. cerevisae. 
 
Test samples 
Zone of inhibition (mm) IC12 (µg/ml) 
RS188N rad52 rad52.top1 rad52 rad52.top1 
Aqueous  11.0 10.0 10.5 7160 4787 
n-BuOH  11.0 12.5 13.0 1910 1641 
MeOH (80%)  8.0 9.0 10.0 3104 2225 
Hexane  10.0 12.0 15.5 1434 542 
Plumericin and Isoplumericin 19.0 23.0 29.0 112.3 32.8 
 










of iridoids could be associated with the DNA damaging 
activity of the latex extract and that it could be topoi-
somerase II inhibitor. The observed activity is important 
not only because it corroborates the ethnopharmacological 
use of the species, but also because it indicates a 
possible synergistic or additive action due to the two 
iridoids since plumericin alone results in less cytotoxicity 
activity (IC12 = 70 µg/ml, rad52.top1) (Wood et al., 2001) 
than that observed in mixture (IC12 = 32.8 µg/ml) .  
The antimicrobial activities of the hexane, chloroform 
and aqueous fractions of H. sucuuba latex were tested 
using the disc diffusion method with seven micro-
organisms and only the last fraction exhibited activity (d = 
17 mm). The antimicrobial activity of the aqueous fraction 
was observed against five bacteria at a concentration of 
500 µg/ml (Proteus mirabilis and Escherichia coli) and 
350 µg/ml (S. aureus, S. epidermis and S. haemolyticus). 
Among the phenolic compounds isolated from the 
aqueous fraction, gallic acid (3), a hydroxybenzoic acid, 
showed the most potent antimicrobial activity (MIC 
values: 31 µg/ml for S. aureus and S. epidermidis, 62 
µg/ml for P. mirabilis and S. haemolyticus and 125 µg/ml 
for E. coli). Gallic acid has been previously reported to 
possess anti-inflammatory, antifungal and antibacterial 
activities (Chanwitheesuk et al., 2007). The flavonoids, 
myricetrin (4) and quercitrin (5), were also isolated from 
the aqueous fraction, but they did not show antibacterial 
activity at any of the concentrations tested. The chemical 
structures of iridoids and phenolic compounds 1 - 5 are 





The results of this phytochemical work on the isolation 
and the identification of the active compounds of the latex 
of H. sucuuba provided scientific validation for the 
popular use of this species, and also confirmed a better 
activity of iridoids mixture on the DNA in a new plant 
material source, which is easier to obtain and less difficult 
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